Treatment of Severe Hypercholesterolemia

Assessment and Treatment

The American Diabetes Association recommends assessing lipid profiles, including total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and VLDL cholesterol, to determine the severity of hypercholesterolemia 1, 2
The American College of Cardiology recommends high-intensity statin therapy as the first-line treatment to achieve ≥50% reduction in LDL-C in patients with severe hypercholesterolemia 2, 3, 4
The American Heart Association suggests that the combination of statin plus ezetimibe can provide additional 15-20% LDL-C reduction 2, 4

The American Diabetes Association recommends checking lipid panel and liver function tests 4-6 weeks after initiating therapy to assess response and tolerability 1, 5
The goal is to achieve ≥50% reduction in LDL-C from baseline, according to the American College of Cardiology 2, 3, 4

The American College of Cardiology suggests that patients with extremely high LDL-C levels (e.g., 386 mg/dL) may have familial hypercholesterolemia and require aggressive therapy 2, 3
The American Heart Association recommends considering intensive lipid-lowering therapy in patients at higher risk for cardiovascular events, such as those aged 65 and older 4